Leber Congenital Amaurosis

First described in 1869 by Theodore Leber.

  • Congenital or Early infancy non-syndromic retinal blindness
  • Searching nystagmus
  • Abnormal pupil reponses
  • “oculodigital sign”- digital eye pressure to induce retinal response
  • Fundus appearance:
    • Initially can have normal fundus appearance followed by pigmentary changes in the retina, vascular attenuation and optic nerve pallor.
    • Bone spicules in macula and periphery
    • Loss of retinal lamination and photoreceptor loss
    • Exudative type retinopathy in CRB1-assoicated disease
    • RPE65-related disease usually has milder peripheral RPE mottling and white dots
  • Disc drusen or pseudopapilledema
  • Severe visual impairment from birth or first few months of life
  • Fundus appearance
    • may be normal
    • Vessel attenuation, disc pallor, peripheral retinal pigmentation
  • ERG is undetectable
  • 70% of patients have a known genetic variant io one of the following genes that preferentially are expressed in the retina or RPE
  • Autosomal Recessive
    • AIPL1, ALMS1, CEP290, CRB1 (photoreceptor cell structure), GUCY2D (Protein trafficking), IMPDH1, LCA5, LRAT (visual cycle function), MERTK, RD3 ,RDH12, RPGRIP1, RPE65 (visual cycle function), SPATA7, KCNJ13, ICQB1, NMNAT1, and TULP1
  • Autosomal Dominant: CRX - photoreceptor cell development

RPE65 Mutations

  • Gene replacement therapy with Luxturna (vortigene neparvovec-rzyl)
    • Adeno-associated virus vector administered subretinally